TILRAY STABLE, OPTIMISTIC
Tilray reported a 126% increase in sales year-over-year, though a US$30M impairment left the company posting an improved net loss of US$184.1 (down from $219.1M last quarter), and a US$19.7M loss in adjusted EBITDA. Net revenue was . . .
Log in or become a WeedWeek Member to read this article.
